2017 Under the Radar: MusicSpoke scores thousands of sheet music sales

August 29, 2017  |  Meghan LeVota

MusicSpoke

Editor’s note: Startland News picked 10 early-stage firms to spotlight for its annual Under the Radar startups list. The following is one of 2017’s companies. To view the full list, click here.

The sheet music publishing industry is worth more than $1 billion.

Yet when working with traditional publishers, composers hardly see any of that money. Models put revenue for publishers as high as 95 percent with only 5 percent slated for composers.

Jennifer Rosenblatt and Kurt Knecht say the trend is pushing composers toward self-publishing as an option, which is why they co-founded MusicSpoke in 2014. Since then, the platform offers more than 1,000 scores and has sold more than 85,000 units of sheet music from self-published composers.

MusicSpoke keeps 30 percent of the sheet music sales, which is significantly lower than traditional publishing fees the sheet music industry, Rosenblatt and Knecht said. The company has grown at an average annual rate of about 260 percent and has raised about $120,000 in investment capital to date.

After spending a decade in Lincoln, Nebraska, Rosenblatt and Knecht set up shop in Kansas City in July 2016. The pair thought their business’ new home would be a better place to grow MusicSpoke.

“We are delighted to be growing in KC,” Rosenblatt said. “We love the support for the arts and entrepreneurship KC provides. We are looking to hire and grow the team next year.”

Later in 2017, MusicSpoke is expected to launch the Icon Series, which involves a collection of scores curated by the industry’s influential conductors, Rosenblatt said. The firm’s tests show that sheet music promoted by an influencer can sell up to 400 percent better than top-selling scores that are not promoted.

Rosenblatt is a 2017 Pipeline Fellow, has participated in ScaleUP KC! and is a part of the Sprint Mentor Network.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , , ,
Featured Business
    Featured Founder

      2017 Startups to Watch

        stats here

        Related Posts on Startland News

        Best in show: Bar K vies for USA Today’s dog bar prize; here’s how a shared love of dogs is pushing expansion

        By Tommy Felts | June 13, 2024

        The human-dog bond — and a desire to embrace it at places like Bar K’s innovative bar, restaurant, and dog park experience — is stronger than today’s often partisan and divisive climate, said David Hensley. “It doesn’t matter your political affiliations … where you’re from, your socioeconomic status,” he said. “Everybody loves dogs, and that…

        Firm with deep KC ties wins Small Business of the Year thanks to tenacity, hyperlocal focus

        By Tommy Felts | June 13, 2024

        Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. A decades-long commitment to Kansas City clients — and the belief that rising tides lift all ships — helped propel Walz Tetrick Advertising to the award stage…

        How this genre-hopping KC musician is fighting back against digitized entertainment

        By Tommy Felts | June 13, 2024

        A former college football star, Keelon Vann often found himself “running on fumes” as he chased his passion on the field — and on key. “I’d be up playing guitar until 3 a.m., which is not a joke, and somehow make it to 5:30 a.m. workouts the next day,” said Vann, a quarterback at Piper High…

        New collaboration will help OP startup 3D bioprint, scale its next-gen biotech solution

        By Tommy Felts | June 12, 2024

        A Kansas biotech startup’s new manufacturing partner will boost efforts to automate and mass produce Ronawk’s headline-grabbing Bio-Block technology — a platform that has already accelerated medical advancements in tissue therapy. “Collaboration is critical for turning research advances into commercial therapies rapidly. The complexity and diversity of modalities is so big that nobody can do…